Carbapenem-induced endotoxin release in gram-negative bacterial sepsis rat models

FEMS Immunol Med Microbiol. 1998 Aug;21(4):297-302. doi: 10.1111/j.1574-695X.1998.tb01177.x.

Abstract

The carbapenem-induced endotoxin release was evaluated using experimental models of gram-negative bacterial sepsis in Wistar rats. Infections with Escherichia coli, Serratia marcescens, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus vulgaris and Proteus mirabilis resulted in an increase of the plasma endotoxin concentration after treatment with ceftazidime and carbapenems including imipenem, panipenem, meropenem and biapenem. Except for P. aeruginosa, the plasma endotoxin concentrations after carbapenem treatment were significantly lower than those after ceftazidime treatment. It is noteworthy that treatment of P. aeruginosa sepsis with meropenem or biapenem induced significantly more endotoxin release than other carbapenems and the endotoxin concentrations induced by these carbapenems reached those of ceftazidime treatment. The plasma endotoxin concentrations appeared to correlate with the reduction of platelet counts and the elevation of both glutamic oxaloacetic transaminase and glutamic pyruvic transaminase values.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Toxins / metabolism*
  • Carbapenems / pharmacology*
  • Disease Models, Animal
  • Endotoxins / metabolism*
  • Enterobacteriaceae / metabolism*
  • Gram-Negative Bacteria / metabolism
  • Pseudomonas aeruginosa / metabolism*
  • Rats
  • Rats, Wistar
  • Sepsis / metabolism*

Substances

  • Bacterial Toxins
  • Carbapenems
  • Endotoxins